Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation

Peroxisome proliferator-activated receptor (PPAR) agonists have been suggested as novel therapeutics for the treatment of inflammatory lung disease, such as allergic asthma. Treatment with PPAR agonists has been shown to inhibit airway eosinophilia in murine models of allergic asthma, which can occu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Smith, Steven G, Hill, Mike, Oliveria, John-Paul, Watson, Brittany M, Baatjes, Adrian J, Dua, Benny, Howie, Karen, Campbell, Heather, Watson, Rick M, Sehmi, Roma, Gauvreau, Gail M
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2014
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080964/
https://ncbi.nlm.nih.gov/pubmed/24628018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12280
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items